Milestone Scientific Stock Performance
| MLSS Stock | USD 1.21 0.01 0.83% |
Milestone Scientific holds a performance score of 15 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.4, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Milestone Scientific will likely underperform. Use Milestone Scientific maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Milestone Scientific.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Milestone Scientific are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Milestone Scientific unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:3 | Last Split Date 2004-01-14 |
1 | Boston Scientific Expands Cardiovascular Treatment Portfolio With 440 Million Bolt Medical Deal | 01/08/2025 |
2 | Is Universal Scientific Industrial Co., Ltd. Trading At A 30 percent Discount | 01/16/2025 |
3 | StockNews.com Initiates Coverage on Milestone Scientific - MarketBeat | 01/28/2025 |
4 | Disposition of 7110 shares by Leonard Osser of Milestone Scientific at 1.33 subject to Rule 16b-3 | 01/29/2025 |
5 | Needham Company LLC Reiterates Hold Rating for Boston Scientific | 02/07/2025 |
6 | Disneys Fortnite Project Reportedly Reaches A Major Milestone | 02/10/2025 |
7 | Soles4Souls Reaches Donation Milestone of 11 Million Pairs of Shoes through Partnership with DSW | 02/11/2025 |
8 | Boston Scientific swings to 3rd-quarter loss | 02/12/2025 |
9 | Orange Bridges Revolutionary Accredited Bitcoin Real Estate Specialist Designation Reaches Milestone | 02/13/2025 |
10 | Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical Scientific Conference | 02/14/2025 |
| Begin Period Cash Flow | 8.7 M | |
| Free Cash Flow | -5.3 M |
Milestone |
Milestone Scientific Relative Risk vs. Return Landscape
If you would invest 64.00 in Milestone Scientific on November 18, 2024 and sell it today you would earn a total of 57.00 from holding Milestone Scientific or generate 89.06% return on investment over 90 days. Milestone Scientific is currently generating 1.2397% in daily expected returns and assumes 6.4439% risk (volatility on return distribution) over the 90 days horizon. In different words, 57% of stocks are less volatile than Milestone, and 76% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Milestone Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Milestone Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Milestone Scientific, and traders can use it to determine the average amount a Milestone Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1924
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MLSS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.44 actual daily | 57 57% of assets are less volatile |
Expected Return
| 1.24 actual daily | 24 76% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Milestone Scientific is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Milestone Scientific by adding it to a well-diversified portfolio.
Milestone Scientific Fundamentals Growth
Milestone Stock prices reflect investors' perceptions of the future prospects and financial health of Milestone Scientific, and Milestone Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Milestone Stock performance.
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (0.52) % | ||||
| Operating Margin | (0.58) % | ||||
| Current Valuation | 89.79 M | ||||
| Shares Outstanding | 77.89 M | ||||
| Price To Earning | (6.39) X | ||||
| Price To Book | 13.05 X | ||||
| Price To Sales | 10.62 X | ||||
| Revenue | 9.83 M | ||||
| Gross Profit | 6.43 M | ||||
| EBITDA | (6.96 M) | ||||
| Net Income | (6.93 M) | ||||
| Cash And Equivalents | 9.81 M | ||||
| Cash Per Share | 0.14 X | ||||
| Total Debt | 395.98 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.95 X | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (5.33 M) | ||||
| Earnings Per Share | (0.06) X | ||||
| Market Capitalization | 94.25 M | ||||
| Total Asset | 11.37 M | ||||
| Retained Earnings | (123.34 M) | ||||
| Working Capital | 7.72 M | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 4.4 M | ||||
About Milestone Scientific Performance
Assessing Milestone Scientific's fundamental ratios provides investors with valuable insights into Milestone Scientific's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Milestone Scientific is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 285.57 | 164.81 | |
| Return On Tangible Assets | (0.56) | (0.59) | |
| Return On Capital Employed | (0.77) | (0.81) | |
| Return On Assets | (0.55) | (0.58) | |
| Return On Equity | (0.99) | (1.04) |
Things to note about Milestone Scientific performance evaluation
Checking the ongoing alerts about Milestone Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Milestone Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Milestone Scientific is way too risky over 90 days horizon | |
| Milestone Scientific may become a speculative penny stock | |
| Milestone Scientific appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 9.83 M. Net Loss for the year was (6.93 M) with profit before overhead, payroll, taxes, and interest of 6.43 M. | |
| Milestone Scientific currently holds about 9.81 M in cash with (5.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
| Milestone Scientific has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Dyne Therapeutics Announces Upcoming Presentations at the 2025 MDA Clinical Scientific Conference |
- Analyzing Milestone Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Milestone Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Milestone Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Milestone Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Milestone Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Milestone Scientific's stock. These opinions can provide insight into Milestone Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.